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Background: In previous reports concerning the association between sex disparity and age, gastric cancer (GC)
patients were simply divided into younger and older groups by age. We analyzed the age trend of the male to
female sex ratio (MFSR) in GC based on patient sequential age in order to observe the changing process of MFSR
with age.
Methods: One thousand seven hundred fifty-one surgical gastric adenocarcinoma patients aged 26 to 85 years
were investigated between January 1996 and December 2010. The patients were grouped by age intervals of
5 years. The Cochran-Armitage trend test was used to determine how the MFSR changed with age.
Results: The median age of the 1,751 patients with GC was 60 years (26 to 85 years). There were 1,334 male and
417 female patients (MFSR was 3.20). Cochran-Armitage trend test analysis showed that total MFSR increased
significantly with age (Z = 5.964, P < 0.0001). Further studies on age groups of 26 to 60 years and 61 to 85 years
were conducted. The trend test showed that MFSR increased significantly with age from 26 to 60 years
(Z = 7.433, P < 0.0001). However, MFSR did not increase in ages 61 to 85 years (Z = -0.607, P = 0.544).
Conclusions: MFSR in GC presented an increasing trend until 60 years of age. The male GC patients showed an
increasing tendency, and female GC patients showed a decreasing tendency with age. This trend reached a plateau
phase after 60 years of age.Background
Gastric cancer (GC) is among the most common malig-
nant tumors worldwide, even taking into consideration
that the incidence of GC has recently decreased in some
countries. In 2008, nearly 995,000 new GC patients were
identified worldwide. Among these new cases, a total of
646,000 were male and 349,000 were female. The male-
female sex ratio (MFSR) was 1.851 [1]. A total of 377,000
new GC cases were estimated to occur in China in 2005;
the MFSR was 2.04 [2]. Similar results were reported by
GLOBOCAN 2008; the male-female sex ratio was 1.84
and 2.13 in the world and China, respectively. Addition-
ally, the male cases were more numerous compared to
female cases in hospitalized GC patients. The MFSR* Correspondence: yujxsd@sohu.com
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unless otherwise stated.from a large series of data for Japanese surgical patients
with GC that was collected from 187 hospitals in 2001
was 2.29:1 [3]. Jeong et al. [4] reported that MFSR was
2.05:1 in data from 14,658 surgical GC patients that were
collected from 59 Korean institutions in 2009. The MFSR
of 1,451 GC patients who underwent surgery from 1999
to 2003 from a single Chinese institute was 2.19:1 [5].
However, male GC patients were not predominant at
every age. Qiu et al. [6] reported that the MFSR increased
with an increase in age. The total MFSR was 2.15:1. But,
the MFSR of young GC patients (aged 50 years or youn-
ger) was 1.39. The MFSR of older GC cases (over 50 years
of age) was 2.64. Chung et al. [7] analyzed 3,242 young
patients with GC between 18 and 45 years of age. The
total MFSR was 1.17. The MFSR were 0.63, 1.01, and
1.67 in 18 to 30-year, 31 to 40-year, 41 to 45-year age
groups, respectively. Thus, the MFSR was lower in young
GC patients compared to older GC patients.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A histogram of male and female gastric cancer
patients by age.
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are sex disparities in GC patients in different age groups.
There may be more female GC patients compared to
males at an early age. Therefore, the number of female
GC patients decreases with age. However, in previous
studies concerning the association between sex disparity
and age, the patients were simply divided into younger
and older groups by age. It has remained unclear how
the MFSR changed; moreover, the time point at which
the change stops has not been elucidated. Thus, in this
study, we analyzed the changing process of MFSR by se-
quential GC patient age in order to observe the age
trend of MFSR in GC. And, we hope our study could
potentially be helpful to explore the factors that influ-
ence the pathogenesis of GC in female adults.
Methods
Patient population
Data were obtained from surgical patients from
Liaocheng People’s Hospital (Shandong, China) from
January 1996 to December 2010. All medical records of
cases diagnosed with GC were reviewed. The patients
with gastric adenocarcinoma were selected. The patients
with GC of other histological types were eliminated. A
total of 1,758 cases with medical records that satisfied
the study requirements were investigated. All patients
were grouped by interval ages of 5 years. Five patients
(three cases were male, two were female) aged 20 to
25 years, and two patients (one from each sex) aged 86 to
88 years, were excluded from the study because the num-
ber of patients was too small to complete an age group.
Finally, a total of 1,751 patients with gastric adenocarcin-
oma were included in this study. The study was approved
by the Ethical Committee of Liaocheng People’s Hospital.
Statistical analysis
The Cochran-Armitage trend test was used to identify
the age trend of MFSR. All analyses were performed
using SAS 9.0 software (SAS Institute Inc., Cary, NC,
USA). Statistical significance was defined as a P value
less than 0.05. All statistical tests were two-sided.
Results
The median age of 1,751 patients with gastric adeno-
carcinoma was 60 years (26 to 85 years). A histogram
of all patient ages according to sex is shown in Figure 1;
there were 1,334 male and 417 female patients. The
MFSR of all GC patients was 3.20. The median age of
patients was 58 years (27 to 84 years) in females and
61 years (26 to 85 years) in males.
The Cochran-Armitage trend test showed that the MFSR
increased significantly with age (Z = 5.964, P < 0.0001) in
total GC cases. The MFSR curve (Basis spline) by each age
group is shown in Figure 2.The Cochran-Armitage trend test was used to analyze
whether there was a variation in trend for MFSR from ages
26 to 60 years and from ages 61 to 85 years. The results
showed that MFSR increased significantly with age from
26 to 60 years (Z = 7.433, P < 0.0001). However, MFSR did
not increase with age from 61 to 85 years (Z = -0.607, P =
0.544). As shown in Figure 2, the MFSR increased until
the 56 to 60 age group, and MFSR reached a plateau after
this age group.
Discussion
To the best of our knowledge, this study is the first to
analyze the age trend of MFSR in GC using a trend test
based on patient sequential age. These results, which are
based on continuous data, are more reliable compared
to previous studies that divided patients simply into
younger and older age groups. The results show that
MFSR increased gradually with age. The percentage of
female GC cases gradually decreased with age. The per-
centage of male GC cases gradually increased with age.
Compared to male GC patients, female patients ex-
hibited a decreasing trend with age. Our results are in
concordance with data from the National Cancer Center
of China. The data from 2003 to 2007 showed that the
male to female incidence ratio of GC was elevated with
age [8]. Rutegard et al. [9] found similar results based
on a study of the sex disparities in GC incidence in
Sweden from 1970 to 2006. The sex (male to female)
ratios of gastric non-cardia gastric adenocarcinoma pre-
sented increasing tendency in the 1970 to 1986 and
1987 to 2006 periods.
The MFSR did not continue to increase after 60 years;
it reached a plateau in our study. The Cochran-Armitage
trend test showed that the MFSR increased gradually in
the 26 to 60 years group but did not increase in the 61
to 85 years group. Our results are supported in a study
by Rutegard et al. [9]. They reported the sex (male to
female) ratios of non-cardia GC patients increased
steadily with age and reached a plateau in the age group
65 to 74 years. The male to female ratio of incidence of
Figure 2 The male-female sex ratio (MFSR) of each age group patients with gastric cancer, and the Basis spline.
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remained almost the same before 30 years of age and
began to increase markedly at 30 years of age, reaching a
plateau after 60 years. Thus, the MFSR in our study was
in conformity with the incidence of GC in China. It is un-
fortunate that the trend of MFSR before 30 years of age
could not statistically analyzed in our study due to lim-
ited data.
There are few studies of the trend of MFSR in GC. This
study did not evaluate why the proportion of female GC
patients showed a decreasing tendency and the propor-
tion of male GC patients showed an increasing tendency
with age. Presumably, male individuals experience a
greater attack from environmental pathogenic factors
(such as H. pylori infection, high salt diet, smoking,
etcetera) compared to females by the time adulthood is
reached. Some studies [10] have suggested that a later
acquisition of H. pylori gastritis in females compared to
males causes later onset of GC. Therefore, the above-
mentioned fact may explain why the proportion of male
GC patients tended to increase after 30 years of age.
Another reason may be the protective effect of estrogen
for GC [11-14]. Duell et al. [15] found that women with
an ovariectomy had a 79% increased risk of GC compared
with women who had no ovariectomy. A population-
based prospective study of women aged 40 to 70 years
was conducted based on 73,442 Shanghai women with
154 GC patients [16]. The results showed that there were
no associations between GC risk and age of menarche,
number of children, breast feeding, or oral contraceptive
use. However, there were associations between GC risk
and age of menopause and years of fertility. Recently, a
meta-analysis demonstrated that exposure to ovarian orexogenous estrogen may decrease the risk of GC [17].
Longer years of fertility (RR = 95% CI: 0.63 to 0.86) and
hormone replacement therapy decreased GC risk (RR =
0.74, 0.77, respectively). However, the age at menarche,
age at menopause, years of fertility, parity, age at first
birth, and oral contraceptive use were not found to be
associated with GC risk. A Korean multicenter cancer
cohort study demonstrated that isoflavone and phytoes-
trogens were associated with decreased risk for GC [18].
Some reports have indicated that treatment with tam-
oxifen, an antiestrogen, increased the incidence of GC
in women and men [12,19].
Conclusions
In conclusion, Cochran-Armitage trend test analysis in-
dicated that the proportion of female GC patients
showed a decreasing tendency and proportion of male
GC patients showed an increasing tendency with age.
However this trend stops after 60 years of age.
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